Paxlovid Use for COVID-19 May Be Feasible in Advanced CKD
Nirmatrelvir/ritonavir is not current recommended for patients with CKD stage 4 or 5, but low-dose regimens could avoid adverse events, according to the authors of a recent editorial.
Nirmatrelvir/ritonavir is not current recommended for patients with CKD stage 4 or 5, but low-dose regimens could avoid adverse events, according to the authors of a recent editorial.
Launch prices for new drugs increased exponentially by 20 percent per year from 2008 to 2021, according to a research letter published.
Women with PCOS at age 46 years report increased morbidity and medication use, irrespective of BMI, compared with women without PCOS.
Inhaled nitric oxide appears to increase the risk for severe acute kidney injury among ICU patients with COVID-19, a French study suggests.
The growth in the number of clinicians with waivers to prescribe buprenorphine slowed during the pandemic.
The U.S. FDA approved the first generic of Symbicort Inhalation Aerosol to treat asthma in patients 6 years and older and for maintenance treatment in patients with COPD.
Tebipenem pivoxil hydrobromide is an orally bioavailable carbapenem with activity against uropathogenic Enterobacterales.
Only 1 in 4 people who could benefit from medication for opioid use disorder (MOUD) receives treatment.
The researchers found that 11 percent of the 19,114 recruited participants reported aspirin use before trial entry, and of these participants, 1,714 reported taking aspirin two or more days per week.
Gilead has “executed seizures at 17 locations in 9 states, seizing thousands of bottles of Gilead-labeled medication with counterfeit supply chain documentation.”